Literature DB >> 3336593

Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters.

J A McMillan1, D A Tristram, L B Weiner, A P Higgins, C Sandstrom, R Brandon.   

Abstract

To assess the possibility that clinical data available at the time of hospital admission for patients with respiratory syncytial virus infection could predict the length of hospitalization without antiviral therapy, the charts of all 102 patients admitted with laboratory documented respiratory syncytial virus infection during 1982 to 1985 were reviewed. Two thirds (65) of the patients remained hospitalized greater than three days. Prolonged hospitalization could have been predicted for 40 of the 65 patients (61.5%) based on the need for intubation and ventilation on admission (14 patients) or the presence of underlying cardiac or respiratory disease (28 patients). Of the infants hospitalized when they were less than 2 months of age, 40% required intubation and mechanical ventilation, although only 16% had underlying cardiac or respiratory disease. Mechanical ventilation was required at the time of admission or subsequently for 14% (5/36) of the 2- to 4-month-old infants with respiratory syncytial virus infection. Among the 56 patients without underlying cardiac or respiratory disease who did not require intubation at the time of admission, 25 (45%) remained hospitalized longer than three days (mean hospital stay for these 25 patients, regardless of age, was six days). Neither the respiratory rate nor the presence or absence of fever on admission was useful in predicting the likelihood of a longer hospital stay for the patients who did not require intubation. In addition, none of the initial laboratory data, including the WBC count, the percentage of band forms or polymorphonuclear leukocytes, the presence or absence of hypoxia, or the chest x-ray film findings could be correlated with a longer or shorter duration of hospitalization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3336593

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.

Authors:  N J Snell
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group.

Authors:  J R Groothuis; M J Levin; W Rodriguez; C B Hall; C E Long; H W Kim; B A Lauer; V G Hemming
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 4.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial.

Authors:  E E Wang; R Milner; U Allen; H Maj
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

6.  Suctioning and length of stay in infants hospitalized with bronchiolitis.

Authors:  Grant M Mussman; Michelle W Parker; Angela Statile; Heidi Sucharew; Patrick W Brady
Journal:  JAMA Pediatr       Date:  2013-05       Impact factor: 16.193

7.  Antibiotic prescribing pattern in paediatric in patients with first time wheezing.

Authors:  Soumya Patra; Varinder Singh; Harish K Pemde; Jagdish Chandra
Journal:  Ital J Pediatr       Date:  2011-09-05       Impact factor: 2.638

8.  Comparison of clinically related factors and treatment approaches in patients with acute bronchiolitis.

Authors:  Özlem Üzüm; Ali Kanık; Kayı Eliaçık; Hacer Örsdemir Hortu; Yavuz Demirçelik; Mehmet Yan; Mehmet Helvacı; Belde Kasap Demir
Journal:  Turk Pediatri Ars       Date:  2020-12-16

Review 9.  Respiratory syncytial virus.

Authors:  O Ruuskanen; P L Ogra
Journal:  Curr Probl Pediatr       Date:  1993-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.